Based on recent data, ADC Therapeutics S.A. (ADCT) shows an Average True Range (ATR) of 0.26 and an Enterprise Value of 241.63M. Its average trading volume over the past 3 months is 1.05M, indicating liquidity. These fundamental metrics provide insight into ADCT's underlying financial health and market activity.
| ATR | 0.26 |
| Enterprise Value | 241.63M |
| Avg Vol (3 Months) | 1.05M |
| Avg Vol (10 Days) | 757.72K |
ADC Therapeutics S.A. (ADCT) technical indicators as of February 7, 2026: the SMA 20 is 7.67%, SMA 50 at 6.43%, and SMA 200 at 20.42%. The RSI 14 value is 57.89, suggesting its current momentum. These technical analysis signals help assess ADCT's price trends and potential future movements.
| SMA 20 | 7.67% |
| SMA 50 | 6.43% |
| SMA 200 | 20.42% |
| RSI 14 | 57.89 |
ADC Therapeutics S.A. (ADCT) stock performance overview as of February 7, 2026: The 52-week high is $4.8 (currently -16.46% below), and the 52-week low is $1.05 (currently 281.9% above). Over the past year, ADCT's performance is 101.14%, compared to the S&P 500's 8.57% change.
| 52-Week High | 4.8 |
| 52-Week High Chg | -16.46% |
| 52-Week Low | 1.05 |
| 52-Week Low Chg | +281.90% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, ADC Therapeutics S.A. (ADCT) stock's recent performance metrics show that over the last month, ADCT is -4.09%, with a Year-to-Date (YTD) performance of -0.28%. Over the past year, the stock has seen a 101.14% change. These figures summarize ADCT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.2 | 4.2 | 4.62 | 4.8 | 4.8 | 4.2 |
| Low | 3.58 | 3.25 | 2.94 | 2.56 | 1.05 | 3.25 |
| Performance | -7.85% | -4.09% | -13.73% | +12.10% | +101.14% | -0.28% |
According to current financial data, ADCT stock's P/E (TTM) ratio is -3.31, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ADCT, including P/S (6.68), P/B (-2.32), and P/FCF (-3.80), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ADCT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.31 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 6.68 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | -2.32 | 709.54 | 9.08 | 5.47 |
| P/FCF (TTM) | -3.8 | -6.89 | -200.6 | 32.07 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep